Compound Detail
CHEMBL4777342
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4777342 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | CJXPNZXEEPSZHK-UHFFFAOYSA-N |
4
Targets
5
Activities
2
Assay Types
1
PK Parameters
20
Publications
0
Known Names
Molecular Properties
418.8
MW (Da)
3.64
ALogP
7
HBA
1
HBD
86.3
PSA (Ų)
0.53
QED
0
Ro5 Violations
5
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 3 meas. best 8.77
Ki 2 meas. best 10.06
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK2 CHEMBL2971 | Ki | 10.06 | 10.06 | 0.1 | 1 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | Ki | 9.68 | 9.68 | 0.2 | 1 |
| Tyrosine-protein kinase JAK1 CHEMBL2835 | IC50 | 8.77 | 8.77 | 1.7 | 1 |
| Janus Kinase (JAK) CHEMBL2363062 | IC50 | 8.33 | 8.33 | 4.7 | 1 |
| Leucine-rich repeat serine/threonine-protein kinase 2 CHEMBL1075104 | IC50 | 7.09 | 7.09 | 81.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 15.0 | mL.min-1.kg-1 | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Tyrosine-protein kinase JAK2 | Ki | = | 0.088 | nM | 10.06 | Inhibition of recombinant human JAK2 (812 to 1132 residues) expressed in insect ... | 30981576 |
| Tyrosine-protein kinase JAK1 | Ki | = | 0.21 | nM | 9.68 | Inhibition of recombinant human JAK1 (854 to 1154 residues) expressed in insect ... | 30981576 |
| Tyrosine-protein kinase JAK1 | IC50 | = | 1.7 | nM | 8.77 | Inhibition of recombinant human GST-tagged JAK1 (866 to 1154 residues) expressed... | 30981576 |
| Janus Kinase (JAK) | IC50 | = | 4.7 | nM | 8.33 | Inhibition of JAK in human BEAS-2B cells assessed as reduction in IL13-induced S... | 30981576 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | IC50 | = | 81.0 | nM | 7.09 | Inhibition of recombinant human GST-tagged LRRK2 (970 to 2527 residues) expresse... | 30981576 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 30981576 | 10.1016/j.bmcl.2019.04.008 | ADMET | 3 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Tyrosine-protein kinase JAK1 | 3 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Tyrosine-protein kinase JAK2 | 2 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Leucine-rich repeat serine/threonine-protein kinase 2 | 2 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Protein kinase C beta type | 2 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | cGMP-dependent protein kinase 1 | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Death-associated protein kinase 1 | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Aurora kinase A | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Tyrosine-protein kinase Yes | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Tyrosine-protein kinase ABL1 | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Proto-oncogene tyrosine-protein kinase Src | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | CDK8/Cyclin C | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Cyclin-dependent kinase 1/cyclin B1 | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | High affinity nerve growth factor receptor | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Proto-oncogene tyrosine-protein kinase ROS | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Tyrosine-protein kinase Fyn | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Non-receptor tyrosine-protein kinase TYK2 | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Tyrosine-protein kinase JAK3 | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | No relevant target | 1 |
| 30981576 | 10.1016/j.bmcl.2019.04.008 | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine